Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06004063

Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

Led by M.D. Anderson Cancer Center · Updated on 2026-04-02

40

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying whether feeding patients after a hematopoietic stem cell transplant using a nasogastric (NG) tube is safe, practical, and acceptable compared to standard nutrition care. This pilot study aims to evaluate the effects of enteral feeding versus parenteral feeding on nutrition, quality of life, survival, medical complications, physical activity, and the gut microbiome in transplant patients. The study is sponsored by M.D. Anderson Cancer Center and involves patients who have planned or current inpatient transplant admission. Participants are randomly assigned to one of two groups. One group receives enteral nutrition delivered directly into the stomach through a nasogastric tube, with dietician monitoring and possible supplemental feeding by vein to meet calorie needs. The other group receives standard care nutrition, which may include oral supplements or parenteral feeding by vein if oral intake is insufficient. The feeding approach depends on the patient's ability to meet caloric goals by mouth. During the study, researchers monitor participants for adverse events using standard criteria, with follow-up for about one year. Dieticians regularly assess nutrition and caloric intake. Additional data such as physical activity from Fitbit devices and stool samples for microbiome analysis may be collected from patients enrolled in related protocols. The study tracks safety, tolerability, quality of life, survival, and medical outcomes to better understand nutrition strategies after stem cell transplant.

CONDITIONS

Brief Title

Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Plans to be admitted or currently admitted for hematopoietic stem cell transplant in an inpatient pediatric or adult ward
  • Age greater than 2 years and less than 25 years at time of enrollment
  • Participants older than 18 or guardians for participants younger than 18 are willing and able to give written informed consent; assent is required for children older than 7 years
  • Participants must speak English, Italian, Chinese/Mandarin, or Spanish
  • Encouraged to co-enroll in related energy-balance protocols, though not required
  • Asked to consider co-enrollment on a stem cell registry study (not required)
Not Eligible

You will not qualify if you...

  • Patients for whom enteral nutrition is contraindicated, such as those with intestinal ischemia or complete bowel obstruction
  • Surgical gastrostomy tube placements solely for study participation are not allowed
  • Female participants who are pregnant, confirmed by a negative pregnancy test within 7 days before transplant according to FACT guidelines

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 1 year or until study completion

Participants receive either enteral nutrition through a nasogastric tube or standard care parenteral nutrition by vein, monitored by a dietician to meet daily caloric needs.

Regular dietician monitoring visits throughout treatment period

Trial Site Locations

Total: 1 location

1

M D Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

S

Shehla Razvi, MD

K

Karen Moody, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here